Optiflow™ High Flow in the Emergency Department

Airvo™ stays with the patient 

Talk to us about Optiflow in your ED
Recognize, stabalize, and mobilize graph

What clinical evidence is there, specific to the ED?

Reducing escalation in ED

Bell. 20151

Higher proportion of patients had > 20% reduction in respiratory rate using NHF: 66.7% NHF vs. 38.5% conventional oxygen therapy (COT), p=0.005.



Showed in an ED randomized control trial that NHF was associated with a lower proportion of patients requiring escalation in ventilation therapy.

Nasal high flow can decrease the need for escalation and might decrease the need for intubation

(Meta-analysis; nasal high flow compared with COT and NIV)

- Huang, et al. Emerg Med Int. 2019.

“Patients with HFNC were much more likely to recover from respiratory failure.”

(Compared with COT in patients with acute hypoxemic respiratory failure)

- Mace, et al. Am J Emerg Med. 2019.

Optiflow in the ED: clinical studies summary

Emergency department clinical studies graph

Flow Matters - ROX index edition

Edition 9.


In this edition, we focus on the newly validated ROX index, a bedside tool designed to predict failure in adults, with acute hypoxemic respiratory failure, being treated with Nasal High Flow. 


Optiflow Adult Clinical Paper Summaries

(PDF 0.8MB)


Optiflow Newsletter - Issue 6

(PDF 0.4MB)


Optiflow Newsletter - Issue 7

(PDF 0.0MB)


Optiflow Therapy Brochure

(PDF 0.9MB)



  1. Bell N, Hutchinson CL, Green TC, Rogan E, Bein KJ, Dinh MM. Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department. Emerg Med Australas. 2015;27(6):537–541
  1. Huang CC, Lan HM, Li CJ, et al. Use High-Flow Nasal Cannula for Acute Respiratory Failure Patients in the Emergency Department: A Meta-Analysis Study. Emerg Med Int. 2019;2019:2130935. Published 2019 Oct 13.
  1. Macé J, Marjanovic N, Faranpour F, et al. Early high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: A before-after study. Am J Emerg Med. 2019;37(11):2091–2096.
  1. Lenglet H, Sztrymf B, Leroy C, Brun P, Dreyfuss D, Ricard JD. Humidified high flow nasal oxygen during respiratory failure in the emergency department: feasibility and efficacy. Respir Care. 2012;57(11):1873–1878.
  1. Jeong JH, Kim DH, Kim SC, et al. Changes in arterial blood gases after use of high-flow nasal cannula therapy in the ED. Am J Emerg Med. 2015;33(10):1344–1349.
  1. Makdee O, Monsomboon A, Surabenjawong U, et al. High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Emergency Department Patients With Cardiogenic Pulmonary Edema: A Randomized Controlled Trial. Ann Emerg Med. 2017;70(4):465–472.e2.
  1. Rittayamai N, Tscheikuna J, Praphruetkit N, Kijpinyochai S. Use of High-Flow Nasal Cannula for Acute Dyspnea and Hypoxemia in the Emergency Department. Respir Care. 2015;60(10):1377–1382.


Optiflow Nasal High Flow



If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.





Select your country of residence

Enter security code
 Security code
By submitting this form, you consent to Fisher & Paykel Healthcare storing your personal information to contact you about your enquiry. Your information will be collected and stored securely by Fisher & Paykel Healthcare Limited based in New Zealand and may be shared with the wider Fisher & Paykel Healthcare group as necessary to support your enquiry. We will not share, disclose or sell your information to third parties for marketing purposes. For full details on how we use and manage your personal information, how long we may retain this information for sales or marketing purposes, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.


Want to receive updates?

Sign up to receive email notifications of the latest product and therapy information as well as upcoming events.

Sign up here

The outbreak of COVID-19 has impacted healthcare organizations around the world

A resource center has been created to provide affected hospitals and healthcare professionals with information they may need to treat patients when using Fisher & Paykel Healthcare products.

View resource center